The problem with this theory is that we can only lay silent for just so long with an empty bank account and trials to finish. This is no time to be either patient or sloppy. You don't sit around on good data when you are facing the prospect of raising money at 40 cents a share, and we aren't getting any approvals without having the money to advance trials.